Xiaflex® is an injectable medication that contains an enzyme meant to break down certain types of collagen. It’s prescribed to treat conditions such as Dupuytren’s contracture and Peyronie’s disease, which involve a buildup of excess collagen.
Xiaflex
*image for illustrative purpose only
Xiaflex
*image for illustrative purpose only
Xiaflex® (collagenase clostridium histolyticum) is an injectable treatment approved by the United States Food and Drug Administration (FDA) to treat conditions involving an excessive buildup of collagen, a structural protein in the body’s connective tissues. These conditions include Dupuytren’s contracture, where thickened tissue causes fingers to bend toward the palm, and Peyronie’s disease, in which scar tissue in the penis causes curved, painful erections.
Xiaflex works by breaking down collagen deposits via the enzyme collagenase, which helps restore mobility and reduce curvature in the affected areas of the body.
In clinical trials, Xiaflex has been shown to effectively reduce penile curvature from Peyronie’s disease without the need for invasive surgery. However, the treatment may cause side effects when used for this condition, such as penile hematoma, penile swelling, and penile pain. Multiple injections may be required for optimal results. Proper administration by a trained healthcare provider is essential in order to minimize risks and maximize benefits.
Xiaflex (collagenase clostridium histolyticum) is indicated for:
The treatment of adult patients with Dupuytren’s contracture with a palpable cord
The treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy
Combination of bacterial collagenases
Dupuytren’s Contracture
The most common adverse reactions reported in ≥25% of patients treated with Xiaflex and at an incidence greater than placebo were:
Edema peripheral (e.g., swelling of the injected hand)
Bruising
Injection site hemorrhage,
Injection site reaction
Pain in the injected extremity
Peyronie’s Disease
The most frequently reported adverse drug reactions reported with ≥25% of patients treated with Xiaflex and at an incidence greater than placebo were:
Penile hematoma
Penile swelling
Penile pain
The cost of Xiaflex may vary depending on where you buy it and your insurance plan. The average retail price of Xiaflex is about $7,430 for one injection, but most health insurance plans cover Xiaflex, and the drug’s manufacturer offers a Copay Assistance Program that reduces the cost to as low as $0 for eligible people. People who do not have health insurance may be eligible to receive Xiaflex free of charge; ask your healthcare provider’s office for more information.
You can get a prescription for Xiaflex after being evaluated by your primary care provider or a specialist who can determine if the medicine is right for you based on factors like your symptoms and medical history.
Peyronie’s plaques that involve the penile urethra
History of hypersensitivity to Xiaflex or to collagenase used in other therapeutic applications
Drug interactions: Anticoagulant drugs
Tendon rupture or serious injury to the injected finger/hand
Corporal rupture (penile fracture) or other serious injury to the penis
Hypersensitivity reactions, including anaphylaxis
Patients with abnormal coagulation: Use with caution
Acute post-injection back pain reactions
Fainting and lightheadedness
WARNING: CORPORAL RUPTURE (PENILE FRACTURE) OR OTHER SERIOUS PENILE INJURY IN THE TREATMENT OF PEYRONIE’S DISEASE
Corporal rupture (penile fracture) was reported as an adverse reaction in 5 of 1044 (0.5%) Xiaflex-treated patients in clinical studies. In other Xiaflex-treated patients (9 of 1044; 0.9%), a diagnosis of corporal rupture cannot be excluded. Severe penile hematoma was also reported as an adverse reaction in 39 of 1044 (3.7%) Xiaflex-treated patients.
Xiaflex is available for the treatment of Peyronie’s disease only through a restricted program called the Xiaflex REMS Program.
There are other treatments for Peyronie’s disease and Dupuytren’s contracture. Some treatments may be better suited to you than others. If you’re interested in an alternative to Xiaflex, connect with a healthcare provider who can help you evaluate your options.
Treatment options for Peyronie’s disease include:
Penile traction therapy, which uses a device designed to stretch the penis
Other injectable medications, including interferon-α2b and verapamil (Verelan®), prescribed off-label at the discretion of a healthcare provider
Oral medications and supplements, such as potassium para-aminobenzoate, vitamin E, or pentoxifylline (Pentoxil®), prescribed off-label at the discretion of a healthcare provider
Treatment options for Dupuytren’s contracture include:
Physical therapy
Radiation
Steroid injections
Surgery
Amputation
Clinical trials on Xiaflex for Peyronie’s disease did not find an association between taking the medication and a shortening of penile length.
No, Xiaflex only comes as an injection that must be administered by a healthcare provider.
There is no generic version of Xiaflex currently available.
Xiaflex is FDA-approved to treat Peyronie’s disease, which can lead to erectile dysfunction (ED), so it may help treat ED associated with Peyronie’s. However, Xiaflex is not a direct treatment for ED.
*This information is from the label for brand name Xiaflex®. See the Full Prescribing Information for more complete information. Collagenase clostridium histolyticum, the active ingredient in Xiaflex, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient collagenase clostridium histolyticum.
Chung E, et al. (2013). Penile traction therapy and Peyronie’s disease: a state of art review of the current literature. https://pmc.ncbi.nlm.nih.gov/articles/PMC3547530/
Denkler KA, et al. (2022). Treatment options for Dupuytren’s disease: tips and tricks. https://pmc.ncbi.nlm.nih.gov/articles/PMC8849405/
Drugs.com. (n.d.). Xiaflex prices, coupons, copay cards, and patient assistance. https://www.drugs.com/price-guide/xiaflex
Krieger JR, et al. (2019). Shockwave therapy in the treatment of Peyronie's disease. https://pubmed.ncbi.nlm.nih.gov/30926460/
National Institute of Diabetes and Digestive and Kidney Diseases. (2019). Penile curvature (Peyronie's disease). https://www.niddk.nih.gov/health-information/urologic-diseases/penile-curvature-peyronies-disease
National Library of Medicine. (2017). Verapamil: MedlinePlus Drug Information. https://pubmed.ncbi.nlm.nih.gov/15774254/
Paulis G, et al. (2013). Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases. https://pubmed.ncbi.nlm.nih.gov/23258640/
Payton S. (2010). Therapeutic benefit of pentoxifylline for Peyronie's disease. https://www.nature.com/articles/nrurol.2010.53
Stewart CA, et al. (2015). Intralesional injection of interferon-α2b improves penile curvature in men with Peyronie's disease independent of plaque location. https://pubmed.ncbi.nlm.nih.gov/26144333/
Weidner W, et al. (2005). Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. https://pubmed.ncbi.nlm.nih.gov/15774254/